ΔF508 and ΔI507 mutations were corrected with ZFN in iPSC from CF patients; after gene correction, the edited iPSC were derived to epithelial monolayer cells, where CFTR function was restored [106]. This evidence concerns the gene CFTR and cystic fibrosis.